Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaa-Hui Dong

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|September 30, 2022
Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort studyYen-Chieh Lee, Yaa-Hui Dong, Wei-Shun Yang, et al.
Journal of the American Heart Association|March 4, 2022
Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial FibrillationShin-Yi Lin, Yu-Chen Chang, Fang-Ju Lin, et al.
Medical Care|September 28, 2011
Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithmRaymond N Kuo, Yaa-Hui Dong, Jen-Pei Liu, et al.
Thorax|October 9, 2012
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trialsYaa-Hui Dong, Hsien-Ho Lin, Wen-Yi Shau, et al.
Drugs - Real World Outcomes|June 27, 2019
Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design StudyHui-Min Diana Lin, Chao-Lun Lai, Yaa-Hui Dong, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 8, 2021
Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort StudyShu-Hui Sun, Chia-Hsuin Chang, Zhe-Wei Zhan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 26, 2025
Risk of Hospitalized Cardiovascular Events Associated with LAMA/LABA/ICS FDC versus LABA/ICS FDC in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Cohort StudyShu-Hui Sun, Marie Jen-Huey Lu, Chun-Yu Chen, et al.
Clinical Pharmacology and Therapeutics|November 6, 2023
Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort StudyYaa-Hui Dong, Jiun-Ling Wang, Chia-Hsuin Chang, et al.
International Journal of Cardiology|December 7, 2016
Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide studyYen-Chieh Lee, Chia-Hsuin Chang, Yaa-Hui Dong, et al.
Diabetes, Obesity & Metabolism|July 6, 2018
Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population-based cohort studyJiun-Ling Wang, Yaa-Hui Dong, Wen-Chien Ko, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|September 30, 2022
Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort studyYen-Chieh Lee, Yaa-Hui Dong, Wei-Shun Yang, et al.
Journal of the American Heart Association|March 4, 2022
Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial FibrillationShin-Yi Lin, Yu-Chen Chang, Fang-Ju Lin, et al.
Medical Care|September 28, 2011
Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithmRaymond N Kuo, Yaa-Hui Dong, Jen-Pei Liu, et al.
Thorax|October 9, 2012
Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trialsYaa-Hui Dong, Hsien-Ho Lin, Wen-Yi Shau, et al.
Drugs - Real World Outcomes|June 27, 2019
Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design StudyHui-Min Diana Lin, Chao-Lun Lai, Yaa-Hui Dong, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 8, 2021
Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort StudyShu-Hui Sun, Chia-Hsuin Chang, Zhe-Wei Zhan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 26, 2025
Risk of Hospitalized Cardiovascular Events Associated with LAMA/LABA/ICS FDC versus LABA/ICS FDC in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Cohort StudyShu-Hui Sun, Marie Jen-Huey Lu, Chun-Yu Chen, et al.
Clinical Pharmacology and Therapeutics|November 6, 2023
Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort StudyYaa-Hui Dong, Jiun-Ling Wang, Chia-Hsuin Chang, et al.
International Journal of Cardiology|December 7, 2016
Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide studyYen-Chieh Lee, Chia-Hsuin Chang, Yaa-Hui Dong, et al.
Diabetes, Obesity & Metabolism|July 6, 2018
Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population-based cohort studyJiun-Ling Wang, Yaa-Hui Dong, Wen-Chien Ko, et al.
Pageof 5